— Posted in Business Expert, CEO

How Sahm Adrangi Approaches Investing

Sahm Adrangi is a New York City businessman who owns and operates a company called Kerrisdale Capital Management. His company operates a hedge fund and he is the chief investment officer. He started this company in 2009 after garnering five years of experience in the financial industry. He graduated from Yale University in 2003 and has an undergraduate degree in economics.

At Kerrisdale Capital Management, Sahm Adrangi specializes investing in stocks that are misunderstood by other investors. Once he and his team spot these misunderstandings he either goes short on the stock of the business or long. He then publishes research showing why other investors have a misconception about the company. His research is published on the Kerrisdale Capital Management website as well as on Twitter and websites that specialize in investing discussions.

Sahm Adrangi has focused on a number of industries to invest his hedge fund in. Among these is the biotechnology industry. He has shorted the stock of a number of companies including Zafgen, Bavarian Nordic, Puls Biosciences, Unilife, and Sage Therapeutics. He also has several years of experience investing in the mining industry. Among the mining prospects he has spotted misunderstandings about are Northern Dynasty Minerals and First Majestic Silver.

Sahm Adrangi has also performed as an investment activist a few times. He lobbied the executives of Lindsay Corporation in 2013, for instance. He wanted them to restructure their cash deployment practices as well as how they allocated capital. In 2014 he began a proxy contest at Morgans Hotel Group. He wanted to replace two of their directors. This led to two of his chosen directors being nominated.

A number of conferences have invited Sahm Adrangi to speak. Among these are Traders 4 a Cause, the Sohn Conference, and the Activist Investor Conference. He has also made media appearances and has been written about in major publications. He has made appearances on both Bloomberg and CNBC. The publications that have written about him include the Washington Post, the Wall Street Journal, Businessweek, and several others. Via twitter